TherapeuticsMD Secretary John Milligan's 2019 pay slips 15% to $1.4M
TherapeuticsMD reports 2019 executive compensation
By ExecPay News
Published: May 4, 2020
TherapeuticsMD reported fiscal year 2019 executive compensation information on May 4, 2020.
In 2019, five executives at TherapeuticsMD received on average a compensation package of $1.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at TherapeuticsMD
John C.K. Milligan, IV, Secretary, received $1.4M in total, which decreased by 15% compared to 2018. 45% of Milligan's compensation, or $646K, was in option awards. Milligan also received $315K in non-equity incentive plan, $450K in salary, as well as $30K in other compensation.
For fiscal year 2019, the median employee pay was $114,000 at TherapeuticsMD. Therefore, the ratio of John C.K. Milligan, IV's pay to the median employee pay was 13 to one.
Robert G. Finizio, Chief Executive Officer, received a compensation package of $1.2M, which decreased by 55% compared to previous year. 49% of the compensation package, or $600K, was in non-equity incentive plan.
Mitchell L. Krassan, Chief Strategy Performance Officer, earned $1M in 2019, a 7% decrease compared to previous year.
Daniel A. Cartwright, Chief Financial Officer, received $1M in 2019, which decreases by 19% compared to 2018.
Michael Donegan, Vice President - Finance, earned $572K in 2019, a 19% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on May 4, 2020.